International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 3431-3434
Case Report
A rare case of Genetic Epilepsy with Febrile Seizure plus (GEFS+) presenting as Landau-Kleffner Syndrome
 ,
 ,
 ,
 ,
 ,
 ,
 ,
Received
Feb. 2, 2026
Accepted
March 16, 2026
Published
April 24, 2026
Abstract

Background: Developmental and Epileptic Encephalopathy (DEE) is a term used by the International League Against Epilepsy (ILAE) to describe a group of severe, early-onset epilepsies. In these conditions, a person’s development is negatively impacted by two distinct factors: the underlying cause of the epilepsy itself and the frequent, severe seizure activity and abnormal brain waves (EEG).

Case Presentation: A 5-year-old male child presented with complaints of altered sensorium. He had h/o multiple episodes of abnormal body movements lasting for about 2-3 minutes and associated with LOC, Tongue bite and incontinence. These episodes started at the age of 11 months of age. At age of 11 months, child developed febrile seizures with semiology – unknown onset GTCS, occurring within 24 hr of fever, lasting up to 30 min. For the next 6 months, child continued to have febrile seizures. Since last 8 months, seizure frequency increased to about 2-3/month with each Seizure lasting 20-30 min & prolonged post ictal phase. Parents noticed that child was less active & had reduced speech output with poor eye contact with paucity of emotional display. EEG showed infrequent to frequent intermittent generalised front central dominant spike and slow waves with preserved sleep architecture. MRI brain showed mild diffuse cerebral atrophy. On genetic study SCN1A gene mutation was there. Patient showed some improvement with immunosuppressive therapy which is IVIg 2mg/kg once and Pulse Inj Methylprednisolone for 6 months.

Conclusion: This case highlights an unusual presentation of LKS Syndrome with multiple episodes of seizure starting as fever induced with mutism and some behavioural symptoms. SCN1A gene mutation was there but secondary mutism favors more towards LKS Syndrome rather than Dravet syndrome.

Keywords
INTRODUCTION

Developmental and Epileptic Encephalopathy (DEE) is a term used by the International League Against Epilepsy (ILAE) to describe a group of severe, early-onset epilepsies. In these conditions, a person’s development is negatively impacted by two distinct factors: the underlying cause of the epilepsy itself and the frequent, severe seizure activity and abnormal brain waves (EEG). [1]

 

Key Components of DEEs

According to the Child Neurology Foundation, DEEs involve a “complex interplay” of three factors:

 

Developmental Encephalopathy: Developmental delay or intellectual disability caused directly by an underlying genetic mutation or brain injury, even if seizures are not occurring.

 

Epileptic Encephalopathy: Frequent seizures and abnormal EEG activity that further worsen or cause a regression in developmental skills.

 

Severe Seizures: These are often drug-resistant and can appear as various types, such as infantile spasms, tonic seizures, or myoclonic jerks.[1]

 

Common DEE Syndromes

Many rare epilepsy syndromes fall under the DEE umbrella, classified based on the age they start and their specific seizure and EEG patterns:

  1. Infantile Epileptic Spasms Syndrome (West Syndrome): Often begins before age 1 with “jackknife” spasms in clusters and a characteristic “hypsarrhythmia” EEG pattern.
  2. Dravet Syndrome: Typically starts in the first year of life with prolonged, fever-triggered seizures, often linked to the SCN1A gene.
  3. Lennox-Gastaut Syndrome (LGS): Usually starts between ages 1 and 8, characterized by multiple seizure types (including tonic “stiffening” seizures) and slow spike-wave EEG patterns.
  4. Early Infantile DEE (EIDEE): A newer group that includes what were formerly called Ohtahara syndrome and Early Myoclonic Encephalopathy.
  5. Landau-Kleffner Syndrome (LKS): A childhood syndrome where a child suddenly or gradually loses language skills (aphasia) in association with abnormal brain waves during sleep.[2]

 

Causes and Management

Causes: The majority are genetic (over 900 linked genes like SCN1A, KCNQ2, and STXBP1), though they can also be caused by structural brain changes, metabolic disorders, or unknown factors.[3]

 

Multimorbidity: Beyond seizures, individuals often face complex challenges including movement disorders, autism, sleep apnoea, gastrointestinal issues, and an increased risk of Sudden Unexpected Death in Epilepsy (SUDEP).

 

Treatment: Management is holistic and includes anti-seizure medications, specialized diets (like the ketogenic diet), and sometimes vagus nerve stimulation (VNS) or brain surgery. [4]

 

While some patients with Dravet might develop features that overlap with other epileptic encephalopathies (like Lennox-Gastaut), LKS specifically represents a focal epilepsy syndrome associated with acquired aphasia.[5]

 

CASE PRESENTATION

A 5-year-old male child presented with complaints of altered sensorium. He had h/o multiple episodes of abnormal body movements lasting for about 2-3 minutes and associated with LOC, Tongue bite and incontinence. These episodes started at the age of 11 months of age. At age of 11 months, child developed febrile seizures with semiology – unknown onset GTCS, occurring within 24 hr of fever, lasting up to 30 min. For the next 6 months, child continued to have febrile seizures. Since last 8 months, seizure frequency increased to about 2-3/month with each Seizure lasting 20-30 min & prolonged post ictal phase. Parents noticed that child was less active & had reduced speech output.

 

The child also had poor eye to eye contact, just able to comprehend few simple commands. There was paucity of emotional display. He was also having difficulty in speech like mouthing of sounds able to produce only monosyllables.

There was history of repetitive movements in the form of inappropriate clicking sounds, grunting. Child was able to comprehend few simple commands from parents. No myoclonic jerks, head drops, absence episodes. Previously child was having normal developmental milestones and birth was uneventful.

 

EEG showed infrequent to frequent intermittent generalised front central dominant spike and slow waves with preserved sleep architecture. MRI brain showed diffuse cerebral atrophy.

 

Due to behavioural symptoms, we suspected LKS Syndrome and planned for immunosuppressive therapy which is IVIg 2mg/kg once and Pulse Inj Methylprednisolone for 6 months. Patient showed some improvement with the treatment.

 

 

FIGURE 1: T2 Weighed MRI Brain showing Mild Diffuse Cerebral Atrophy

 

Figure 2: EEG Showing frequent intermittent generalised frontocentral dominant spike and slow waves with preserved sleep architecture.

 

Figure 3: Patient is having mutation at SCN1A,SCN1B and GALNT3 Gene locus

 

DISCUSSION

Landau-Kleffner Syndrome (LKS) is a childhood syndrome where a child suddenly or gradually loses language skills (aphasia) in association with abnormal brain waves during sleep whereas Dravet Syndrome Typically starts in the first year of life with prolonged, fever-triggered seizures, often linked to the SCN1A gene.

 

This case highlights an unusual presentation of LKS Syndrome with multiple episodes of seizure starting as fever induced with mutism and some behavioural symptoms. SCN1A gene mutation was there but secondary mutism favours more towards LKS Syndrome rather than Dravet syndrome.

 

REFERENCES

  1. Chapman KE, Haubenberger D, Jen E, Tishchenko A, Nguyen T, McMicken C. Unmet needs in epileptic encephalopathy with spike-and-wave activation in sleep: A systematic review. Epilepsy Res. 2024 Jan;199:107278. doi: 10.1016/j.eplepsyres.2023.107278. Epub 2023 Dec 8. PMID: 38157757.
  2. Muzio MR, Cascella M, Al Khalili Y. Landau-Kleffner Syndrome. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 31613525.
  3. Kawai M, Abe Y, Yumoto M, Kubota M. Aphasia and a Dual-Stream Language Model in a 4-Year-Old Female with Landau-Kleffner Syndrome. Neuropediatrics. 2022 Aug;53(4):295-298. doi: 10.1055/s-0041-1733983. Epub 2021 Dec 1. PMID: 34852374.
  4. Caraballo RH, Cejas N, Chamorro N, Kaltenmeier MC, Fortini S, Soprano AM. Landau-Kleffner syndrome: a study of 29 patients. Seizure. 2014 Feb;23(2):98-104. doi: 10.1016/j.seizure.2013.09.016. Epub 2013 Oct 8. PMID: 24315829.
  5. van der Meulen I, Pangalila RF, van de Sandt-Koenderman WME. Cognitive linguistic Treatment in Landau Kleffner Syndrome: Improvement in Daily Life Communication. Child Neurol Open. 2021 Jun 2;8:2329048X211022196. doi: 10.1177/2329048X211022196. PMID: 34124282; PMCID: PMC8175838.
Recommended Articles
Review Article Open Access
Digital Health Literacy and Health Information-Seeking Behaviour Among Young Adults: A Narrative Review
2026, Volume-7, Issue 1 : 3231-3236
Case Report Open Access
Unilateral Variation in Origin and Course of Profunda Femoris: A Case Report
2026, Volume-7, Issue 2 : 3427-3430
Case Report Open Access
Siamese Twins Double Monsters
2026, Volume-7, Issue 2 : 3424-3426
Research Article Open Access
The New BPaLM and BPaL Regimens for Drug-Resistant Tuberculosis in India (2025–2026): A Systematic Review of Efficacy, Safety, and Programmatic Implementation
2026, Volume-7, Issue 2 : 3444-3454
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
4 Views
6 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved